EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models

Julia Minnee, Wallace Zh Wong, Benjamin S Russell, Jose Lm Semana, Ruofan Li, Nathaniel R Landau, Takuya Tada

Journal for ImmunoTherapy of Cancer · 2025-12 · 13 (12) · e013040

DOI: 10.1136/jitc-2025-013040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 31.12.2025. Verfasst von Julia Minnee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Melanoma, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chimeric antigen receptor (CAR)-T cell therapy has been successful for the treatment of hematological cancers but less effective against solid tumors, a phenomenon that results from the immunosuppressive nature of the tumor microenvironment. As a strategy to improve the treatment of solid tumors, we applied CAR therapy to dendritic cells (DCs) to generate CAR-DCs. The CAR targeted the human epidermal growth factor receptor 2 (HER2) which is overexpressed in breast cancer to defeat the immunosuppressive nature of the tumor microenvironment.

Methods

CAR-DCs were generated by lentiviral vector transduction of SAMHD1 knock-out murine bone marrow-derived DCs. The vectors coexpressed CD40L and a soluble form of programmed cell death 1 (PD-1), a checkpoint inhibitor. To increase the durability of CAR-DCs, a gene encoding the cytokine GM-CSF was introduced into the CAR vector. The CAR-DCs were injected into mice bearing B16.HER2 melanoma tumors. Tumor growth was measured, and T cell functionality was determined by IFNγ expression and in vitro cytolytic assay.

Results

CAR-DCs suppressed the growth of B16.HER2 tumors and induced the proliferation and activation of tumor-infiltrating cytolytic CD8+T cells. The PD-1 checkpoint inhibitor further augmented the antitumor response and prevented T cell exhaustion. Vectored expression of GM-CSF increased the durability of the antitumor response.

Conclusions

CAR-DCs could be an effective strategy for therapies against solid tumors that should be further explored. The approach relies on the antigen-presenting ability of DCs and their role in T cell activation and can be coupled with checkpoint inhibition in place of monoclonal antibody treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsReceptors, Chimeric AntigenImmunotherapy, AdoptiveMelanoma, ExperimentalAnimalsMiceHumansFemaleTumor MicroenvironmentDisease Models, AnimalErb-b2 Receptor Tyrosine KinasesMice, Inbred C57BLCell Line, Tumor

Stichwörter der Autor:innen

Chimeric antigen receptor - CARDendriticImmune Checkpoint InhibitorImmunotherapy

Substanzen

Receptors, Chimeric AntigenErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA.
  • Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA nathaniel.landau@med.nyu.edu.

Förderung

  • Foundation for the National Institutes of Health

Zitieren

APA

Minnee, J., Wong, W. Z., Russell, B. S., Semana, J. L., Li, R., Landau, N. R., & Tada, T. (2025). Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models. Journal for ImmunoTherapy of Cancer, 13(12), e013040. https://doi.org/10.1136/jitc-2025-013040

Vancouver

Minnee J, Wong WZ, Russell BS, Semana JL, Li R, Landau NR, et al. Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models. Journal for ImmunoTherapy of Cancer. 2025;13(12):e013040. doi:10.1136/jitc-2025-013040

BibTeX
@article{Minnee2025,
  author = {Minnee, Julia and Wong, Wallace Zh and Russell, Benjamin S and Semana, Jose Lm and Li, Ruofan and Landau, Nathaniel R and Tada, Takuya},
  title = {Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {12},
  pages = {e013040},
  doi = {10.1136/jitc-2025-013040}
}
Kostenlos starten →